Advancing molecular tumour boards: highly needed to maximise the impact of precision medicine

ESMO Open. 2019 Apr 20;4(2):e000516. doi: 10.1136/esmoopen-2019-000516. eCollection 2019.

Joris van de Haar^#^{1

2}, Louisa Hoes^#^{1

2}, Emile Voest^{1

2}

¹ Department of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
² Netherlands Cancer Institute, Oncode Institute, Amsterdam, The Netherlands.

^# Contributed equally.

No abstract available

Keywords: genomics; molecular tumour board; oncology; precision oncology.

Publication types